Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Mei Pharma Inc (MEIP)

2.33 +0.01 (+0.43%)

10/17/2017  3:59pm

Open:

2.34

Pre. Close:

2.32

High:

2.37

Low:

2.30

Volume:

193,439

Market Cap:

86.07M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.41 - 2.49

2.49 - 2.61

Low:

2.15 - 2.2

2.2 - 2.28

Close:

2.23 - 2.31

2.31 - 2.43

Technical analysis  (as of: 2017-10-17 4:39:57 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 3.04     One year: 3.29

Support:

Support1: 2.25    Support2: 1.87

Resistance:

Resistance1: 2.60    Resistance2: 2.82

Pivot:

2.53

Moving Averages:

MA(5): 2.35     MA(20): 2.58

MA(100): 2.57     MA(250): 1.98

MACD:

MACD(12,26): -0.10     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 11.96     %D(3): 9.26

RSI:

RSI(14): 30.15

52-Week:

High: 3.26  Low: 1.34  Change(%): 43.8

Average Vol(K):

3-Month: 20118  10-Days 9790

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MEIP has closed above bottom band by 18.3%. Bollinger Bands are 14.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 03 Apr 2017 12:00:00 GMT
MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer

Tue, 19 Sep 2017 13:07:30 GMT
MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference

Tue, 05 Sep 2017 20:37:30 GMT
MEI Pharma nabs rights to oncology candidate voruciclib

Tue, 05 Sep 2017 12:36:47 GMT
MEI Pharma Reports Fiscal Year 2017 Results

Tue, 17 Oct 2017 04:07:30 GMT
Analysts See $-0.17 EPS for MEI Pharma Inc (MEIP)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

34.27

% Held by Insiders

8.55

% Held by Institutions

18.30

Shares Short (K)

376

Shares Short Prior Month (K)

348

Stock Financials

EPS

0.070

EPS Est. Current Year

-1.150

EPS Est. Next Year

-1.380

EPS Est. Next Quarter

-0.310

Forward EPS

-1.381

Book Value (p.s.)

1.380

PEG Ratio

20.60

Profit Margin

11.48

Operating Margin

10.25

Return on Assets (ttm)

2.9

Return on Equity (ttm)

5.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.494

Sales Per Share

EBITDA (p.s.)

0.067

Qtrly Earnings Growth

Operating Cash Flow (M)

3.49

Levered Free Cash Flow (M)

2.25

FoxReading.com

Valuation

P/E

33.29

P/E Growth Ratio

P/BV

1.69

P/S

136619360.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-12-19

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.